These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 22215208)

  • 1. Kynurenic acid: a metabolite with multiple actions and multiple targets in brain and periphery.
    Moroni F; Cozzi A; Sili M; Mannaioni G
    J Neural Transm (Vienna); 2012 Feb; 119(2):133-9. PubMed ID: 22215208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G-protein coupled receptor 35 (GPR35) activation and inflammatory pain: Studies on the antinociceptive effects of kynurenic acid and zaprinast.
    Cosi C; Mannaioni G; Cozzi A; Carlà V; Sili M; Cavone L; Maratea D; Moroni F
    Neuropharmacology; 2011 Jun; 60(7-8):1227-31. PubMed ID: 21110987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term systemic administration of kynurenic acid brain region specifically elevates the abundance of functional CB
    Zádor F; Nagy-Grócz G; Dvorácskó S; Bohár Z; Cseh EK; Zádori D; Párdutz Á; Szűcs E; Tömböly C; Borsodi A; Benyhe S; Vécsei L
    Neurochem Int; 2020 Sep; 138():104752. PubMed ID: 32445659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications.
    Hilmas C; Pereira EF; Alkondon M; Rassoulpour A; Schwarcz R; Albuquerque EX
    J Neurosci; 2001 Oct; 21(19):7463-73. PubMed ID: 11567036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GPR35 activation reduces Ca2+ transients and contributes to the kynurenic acid-dependent reduction of synaptic activity at CA3-CA1 synapses.
    Berlinguer-Palmini R; Masi A; Narducci R; Cavone L; Maratea D; Cozzi A; Sili M; Moroni F; Mannaioni G
    PLoS One; 2013; 8(11):e82180. PubMed ID: 24312407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kynurenic acid leads, dopamine follows: a new case of volume transmission in the brain?
    Wu HQ; Rassoulpour A; Schwarcz R
    J Neural Transm (Vienna); 2007 Jan; 114(1):33-41. PubMed ID: 16932989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kynurenic acid analogues with improved affinity and selectivity for the glycine site on the N-methyl-D-aspartate receptor from rat brain.
    Foster AC; Kemp JA; Leeson PD; Grimwood S; Donald AE; Marshall GR; Priestley T; Smith JD; Carling RW
    Mol Pharmacol; 1992 May; 41(5):914-22. PubMed ID: 1375317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age dependency of inhibition of alpha7 nicotinic receptors and tonically active N-methyl-D-aspartate receptors by endogenously produced kynurenic acid in the brain.
    Alkondon M; Pereira EF; Eisenberg HM; Kajii Y; Schwarcz R; Albuquerque EX
    J Pharmacol Exp Ther; 2011 Jun; 337(3):572-82. PubMed ID: 21270133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotinylalanine increases the formation of kynurenic acid in the brain and antagonizes convulsions.
    Russi P; Alesiani M; Lombardi G; Davolio P; Pellicciari R; Moroni F
    J Neurochem; 1992 Dec; 59(6):2076-80. PubMed ID: 1431895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of kynurenines in the central and peripheral nervous systems.
    Németh H; Toldi J; Vécsei L
    Curr Neurovasc Res; 2005 Jul; 2(3):249-60. PubMed ID: 16181118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two receptors are involved in the central functions of kynurenic acid under an acute stress in neonatal chicks.
    Yoshida J; Shigemura A; Ogino Y; Denbow DM; Furuse M
    Neuroscience; 2013 Sep; 248():194-200. PubMed ID: 23769910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiological characterisation of the actions of kynurenic acid at ligand-gated ion channels.
    Mok MH; Fricker AC; Weil A; Kew JN
    Neuropharmacology; 2009 Sep; 57(3):242-9. PubMed ID: 19523966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term exposure to nicotine markedly reduces kynurenic acid in rat brain--in vitro and ex vivo evidence.
    Zielińska E; Kuc D; Zgrajka W; Turski WA; Dekundy A
    Toxicol Appl Pharmacol; 2009 Oct; 240(2):174-9. PubMed ID: 19616570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted deletion of the kynurenine aminotransferase ii gene reveals a critical role of endogenous kynurenic acid in the regulation of synaptic transmission via alpha7 nicotinic receptors in the hippocampus.
    Alkondon M; Pereira EF; Yu P; Arruda EZ; Almeida LE; Guidetti P; Fawcett WP; Sapko MT; Randall WR; Schwarcz R; Tagle DA; Albuquerque EX
    J Neurosci; 2004 May; 24(19):4635-48. PubMed ID: 15140935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kynurenic acid and its analogue can alter the opioid receptor G-protein signaling after acute treatment via NMDA receptor in rat cortex and striatum.
    Samavati R; Zádor F; Szűcs E; Tuka B; Martos D; Veres G; Gáspár R; Mándity IM; Fülöp F; Vécsei L; Benyhe S; Borsodi A
    J Neurol Sci; 2017 May; 376():63-70. PubMed ID: 28431630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial remodeling and ischemic protection by G protein-coupled receptor 35 agonists.
    Wyant GA; Yu W; Doulamis IP; Nomoto RS; Saeed MY; Duignan T; McCully JD; Kaelin WG
    Science; 2022 Aug; 377(6606):621-629. PubMed ID: 35926043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The kynurenic acid hypothesis - a new look at etiopathogenesis and treatment of schizophrenia].
    Flis M; Szymona K; Morylowska-Topolska J; Urbańska A; Krukow P; Kandefer-Szerszeń M; Zdzisińska B; Urbańska EM; Karakuła-Juchnowicz H
    Pol Merkur Lekarski; 2016 Sep; 41(243):160-164. PubMed ID: 27755520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of aryl hydrocarbon receptors increases endogenous kynurenic acid levels and protects mouse brain against excitotoxic insult and oxidative stress.
    García-Lara L; Pérez-Severiano F; González-Esquivel D; Elizondo G; Segovia J
    J Neurosci Res; 2015 Sep; 93(9):1423-33. PubMed ID: 26013807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kynurenic acid inhibits the release of the neurotrophic fibroblast growth factor (FGF)-1 and enhances proliferation of glia cells, in vitro.
    Di Serio C; Cozzi A; Angeli I; Doria L; Micucci I; Pellerito S; Mirone P; Masotti G; Moroni F; Tarantini F
    Cell Mol Neurobiol; 2005 Sep; 25(6):981-93. PubMed ID: 16392031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kynurenic acid, by targeting α7 nicotinic acetylcholine receptors, modulates extracellular GABA levels in the rat striatum in vivo.
    Beggiato S; Antonelli T; Tomasini MC; Tanganelli S; Fuxe K; Schwarcz R; Ferraro L
    Eur J Neurosci; 2013 May; 37(9):1470-7. PubMed ID: 23442092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.